MICHAEL ALBRIGHT: Open Payments
NPI 1184047912 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 57 payments from 19 companies in 2025. Trend: 2023 $1,512 · 2024 $1,971 · 2025 $1,404
Food & beverage: $1,304Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $333 |
| PFIZER INC. | 5 | $116 |
| Endo USA, Inc. | 5 | $109 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| SEAGEN INC. | 1 | $100 |
| ABBVIE INC. | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $83 |
| Dendreon Pharmaceuticals LLC | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $59 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $48 |
Products named: ORGOVYX, XTANDI, GEMTESA, ERLEADA, XIAFLEX, LYNPARZA, PROVENGE, LUPRON DEPOT.
Industry payments across NC — which companies pay providers there.
